Rupali Doshi

489 total citations
24 papers, 318 citations indexed

About

Rupali Doshi is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Rupali Doshi has authored 24 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Epidemiology and 4 papers in General Health Professions. Recurrent topics in Rupali Doshi's work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (12 papers) and HIV Research and Treatment (4 papers). Rupali Doshi is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (12 papers) and HIV Research and Treatment (4 papers). Rupali Doshi collaborates with scholars based in United States, India and Canada. Rupali Doshi's co-authors include Laura W. Cheever, John Milberg, Faye Malitz, Deborah Isenberg, Thomas R. Matthews, Louis DeSantis, David J. Malebranche, Lisa Bowleg, Thurka Sangaramoorthy and Michael L. Chandler and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Rupali Doshi

19 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupali Doshi United States 10 209 168 99 41 37 24 318
J. Fontaine France 4 256 1.2× 212 1.3× 98 1.0× 54 1.3× 81 2.2× 7 371
Larissa Otero Peru 15 387 1.9× 305 1.8× 37 0.4× 10 0.2× 12 0.3× 39 499
Guoshen Wang United States 11 218 1.0× 168 1.0× 90 0.9× 37 0.9× 68 1.8× 30 314
M. C. Donoghoe United Kingdom 9 177 0.8× 362 2.2× 84 0.8× 31 0.8× 84 2.3× 22 430
Rebekkah S. Robbins United States 11 294 1.4× 259 1.5× 98 1.0× 62 1.5× 31 0.8× 21 408
Jennifer Hecht United States 7 263 1.3× 236 1.4× 78 0.8× 24 0.6× 138 3.7× 19 341
Karen Champenois France 11 284 1.4× 235 1.4× 31 0.3× 120 2.9× 48 1.3× 26 374
Otilia Bisbal Spain 8 199 1.0× 127 0.8× 30 0.3× 83 2.0× 34 0.9× 28 272
Claire Edmundson United Kingdom 8 151 0.7× 256 1.5× 31 0.3× 14 0.3× 67 1.8× 17 353

Countries citing papers authored by Rupali Doshi

Since Specialization
Citations

This map shows the geographic impact of Rupali Doshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Doshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Doshi more than expected).

Fields of papers citing papers by Rupali Doshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupali Doshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Doshi. The network helps show where Rupali Doshi may publish in the future.

Co-authorship network of co-authors of Rupali Doshi

This figure shows the co-authorship network connecting the top 25 collaborators of Rupali Doshi. A scholar is included among the top collaborators of Rupali Doshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupali Doshi. Rupali Doshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Souza, Valerian T., et al.. (2025). In vivo subcutaneous biocompatibility evaluation of decellularized tilapia fish skin in a rat model. Scientific Reports. 15(1). 37982–37982.
2.
Patel, Viraj V., Rebecca Zimba, Chloe Mirzayi, et al.. (2025). Preferences for HIV preexposure prophylaxis care among gay, bisexual, and other MSM: a large discrete choice experiment. AIDS. 39(7). 905–911. 1 indexed citations
3.
Byrne, Morgan, Anne K. Monroe, Rupali Doshi, Michael A. Horberg, & Amanda D. Castel. (2024). A Latent Class Analysis of Substance Use and Longitudinal HIV RNA Patterns Among PWH in DC Cohort. AIDS and Behavior. 28(2). 682–694.
4.
Dorsey, Kerri, et al.. (2023). Risk Factors for Human Papillomavirus-Associated Cancers Among People Living with HIV in Washington, District of Columbia. AIDS Research and Human Retroviruses. 39(4). 195–203. 1 indexed citations
5.
Doshi, Rupali, Shawnika J. Hull, Aaron Broun, et al.. (2023). Lessons learned from U.S. rapid antiretroviral therapy initiation programs. International Journal of STD & AIDS. 34(13). 945–955. 2 indexed citations
6.
7.
Doshi, Rupali, Morgan Byrne, Matthew E. Levy, et al.. (2021). Association of Substance Use Disorders with Engagement in Care and Mortality among a Clinical Cohort of People with HIV in Washington, DC. AIDS and Behavior. 25(7). 2289–2300. 9 indexed citations
8.
Doshi, Rupali, et al.. (2020). Knowledge, Attitudes, and Behaviors Related to Hepatitis C Screening and Treatment among Health Care Providers in Washington, DC. Journal of Community Health. 45(4). 785–794. 9 indexed citations
9.
Akselrod, Hana, Matthew E. Levy, Morgan Byrne, et al.. (2020). Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort. Sexually Transmitted Infections. 96(2). 89–95. 13 indexed citations
10.
Opoku, Jenevieve, Rupali Doshi, Amanda D. Castel, et al.. (2019). Comparison of Clinical Outcomes of Persons Living With HIV by Enrollment Status in Washington, DC: Evaluation of a Large Longitudinal HIV Cohort Study. JMIR Public Health and Surveillance. 6(2). e16061–e16061. 12 indexed citations
11.
Levy, Matthew E., Anne K. Monroe, Michael A. Horberg, et al.. (2019). Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(3). 329–341. 6 indexed citations
12.
Doshi, Rupali, et al.. (2018). Cross-Jurisdictional Data Exchange Impact on the Estimation of the HIV Population Living in the District of Columbia: Evaluation Study. JMIR Public Health and Surveillance. 4(3). e62–e62. 6 indexed citations
13.
Doshi, Rupali, et al.. (2017). For Many Served By The Ryan White HIV/AIDS Program, Disparities In Viral Suppression Decreased, 2010–14. Health Affairs. 36(1). 116–123. 39 indexed citations
14.
Doshi, Rupali, John Milberg, Deborah Isenberg, et al.. (2014). High Rates of Retention and Viral Suppression in the US HIV Safety Net System: HIV Care Continuum in the Ryan White HIV/AIDS Program, 2011. Clinical Infectious Diseases. 60(1). 117–125. 89 indexed citations
15.
Doshi, Rupali, Nicholas Vogenthaler, Sarah Lewis, et al.. (2012). Correlates of Antiretroviral Utilization Among Hospitalized HIV-Infected Crack Cocaine Users. AIDS Research and Human Retroviruses. 28(9). 1007–1014. 11 indexed citations
16.
Doshi, Rupali, David J. Malebranche, Lisa Bowleg, & Thurka Sangaramoorthy. (2012). Health Care and HIV Testing Experiences Among Black Men in the South: Implications for “Seek, Test, Treat, and Retain” HIV Prevention Strategies. AIDS Patient Care and STDs. 27(2). 123–133. 37 indexed citations
17.
Doshi, Rupali, et al.. (2010). Acute Cholecystitis Caused by NontoxigenicVibrio choleraeO1 Inaba. Journal of Clinical Microbiology. 48(3). 1002–1004. 5 indexed citations
18.
Doshi, Rupali, et al.. (2009). Healthcare‐associated Infections: Epidemiology, Prevention, and Therapy. Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine. 76(1). 84–94. 29 indexed citations
19.
Kapin, Michael A., Rupali Doshi, B. Scatton, Louis DeSantis, & Michael L. Chandler. (1999). Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.. PubMed. 40(6). 1177–82. 43 indexed citations
20.
Chandler, Michael L., Iok‐Hou Pang, Rupali Doshi, et al.. (1997). In vitro and in vivo protective effects of eliprodil in the retina. Investigative Ophthalmology & Visual Science. 38(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Fontaine Breakdown of academic impact, for papers by Larissa Otero Breakdown of academic impact, for papers by Guoshen Wang Breakdown of academic impact, for papers by M. C. Donoghoe Breakdown of academic impact, for papers by Rebekkah S. Robbins Breakdown of academic impact, for papers by Jennifer Hecht Breakdown of academic impact, for papers by Karen Champenois Breakdown of academic impact, for papers by Otilia Bisbal Breakdown of academic impact, for papers by Claire Edmundson
Rankless by CCL
2026